Novartis eye unit subpoenaed in U.S. probe

Novartis ($NVS) has disclosed a U.S. government probe into alleged healthcare fraud at its newly acquired eyecare unit Alcon, Reuters reports. The company received a subpoena from HHS, requesting documents involving sales of four drugs, including Vigamox and Nevanac, and surgical equipment. Report